Latest DMAC reports update at 2024-05-08: 2024-Q1 ∙ 2023-Q4 ∙ 2023-Q1
  1. Home
  2. Stock quotes
  3. DiaMedica Therapeutics
  4. Financial Statements
DiaMedica Therapeutics logo
DiaMedica Therapeutics DMAC
$ 3.25 -6.34%
mail-toReport an Error

DiaMedica Therapeutics Financial Statements 2011-2024 | DMAC

Annual Financial Statements DiaMedica Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

 91.8 M 42 M 53.8 M 134 M 49.9 M 29.6 M 27.3 M 12 M 7.92 M 2.98 M 44.3 M 48.5 M -

Shares

 32.6 M 26.4 M 20.8 M 16.7 M 12 M 7.74 M 5.94 M 4.74 M 3.62 M 3.04 M 2.73 M 2.45 M -

Historical Prices

 2.82 1.59 2.59 8.03 4.36 3.9 5.36 2.28 2.18 0.98 16.2 19.8 -

Net Income

 -19.4 M -13.7 M -13.6 M -12.3 M -10.6 M -5.73 M -4.26 M -2.22 M -1.44 M -4.82 M -7.41 M -10.1 M -6.61 M

Revenue

 - - - - - 500 K - - - - - - -

Cost of Revenue

 - - - - - - - - - - - - -

Gross Profit

 - - - - - - - - - - - - -

Operating Income

 -21.3 M -14 M -13.6 M -12.7 M -11.6 M -6.76 M -4.52 M - - - - - -

Interest Expense

 1.93 M 353 K 82 K 229 K 119 K -68 K 6 K - - - - - -

EBITDA

 -21.2 M -14 M -13.6 M -12.5 M -10.7 M -5.53 M -4.28 M -2.26 M -1.39 M -4.83 M -6.32 M -7.7 M -4.35 M

Operating Expenses

 21.3 M 14 M 13.6 M 12.5 M 10.7 M - - - - - - - -

General and Administrative Expenses

 8.16 M 6.16 M 4.88 M 4.39 M 3.69 M 2.74 M 1.31 M 718 K 423 K 1.12 M 2.54 M 2.53 M 2.08 M

All numbers in USD currency

Quarterly Income Statement DiaMedica Therapeutics

2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

 38 M 38 M 37.9 M 27.3 M 26.4 M 26.4 M 26.4 M 26.4 M 26.4 M 26.4 M 19 M 18.8 M 18.8 M 18.7 M 16.7 M 14.1 M 13.1 M 12 M 12 M 12 M 12 M 12 M 7.84 M 7.82 M 6.55 M 6.37 M - - - - - - - - - - - - - - - - - - - - - - - - - - -

Net Income

 -5.15 M - -4.47 M -4.48 M -5.27 M - -3.06 M -3.36 M -3.51 M - -3.45 M -3.27 M -3.62 M - -3.19 M -2.47 M -2.42 M - -2.45 M -2.47 M -3.25 M - -1.39 M -1.74 M -650 K - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Revenue

 - - - - - - - - - - - - - - - - - - - - - - 500 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Cost of Revenue

 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Gross Profit

 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Income

 -5.74 M - -5.16 M -4.74 M -5.52 M - -3.13 M -3.36 M -3.54 M - -3.42 M -3.36 M -3.62 M - -3.32 M -2.71 M -2.4 M - -2.66 M -2.74 M -3.42 M - -1.49 M -1.85 M -1.31 M - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Interest Expense

 597 K - 693 K 271 K 256 K - 76 K 13 K 35 K - -27 K 98 K 4 K - 103 K 178 K -127 K - -38 K 54 K 4 K - -39 K 13 K -35 K - - - - - - - - - - - - - - - - - - - - - - - - - - - -

EBITDA

 -5.73 M - - - -5.51 M - -3.11 M -3.35 M -3.53 M - -3.4 M -3.35 M -3.61 M - -3.3 M -2.7 M -2.4 M - -2.64 M -2.73 M -3.42 M - -1.48 M -1.84 M -1.3 M - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Expenses

 - - - - - - - - - - - - - - - - - - - - 3.42 M - - - 1.31 M - - - - - - - - - - - - - - - - - - - - - - - - - - - -

General and Administrative Expenses

 2.06 M - 1.88 M 2.2 M 1.9 M - 1.49 M 1.41 M 1.56 M - 1.08 M 1.21 M 1.21 M - 1.16 M 1.11 M 1.06 M - 1.04 M 867 K 814 K - 777 K 780 K 515 K - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency